Provided by Tiger Trade Technology Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

0.4747
-0.0013-0.27%
Post-market: 0.4745-0.0002-0.04%18:06 EST
Volume:19.55K
Turnover:9.10K
Market Cap:19.50M
PE:-2.11
High:0.4770
Open:0.4702
Low:0.4600
Close:0.4760
52wk High:3.42
52wk Low:0.4351
Shares:41.08M
Float Shares:3.40M
Volume Ratio:0.09
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2245
EPS(LYR):-0.2509
ROE:-145.11%
ROA:-86.11%
PB:2.00
PE(LYR):-1.89

Loading ...

Anebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan

TIPRANKS
·
Feb 06

BRIEF-Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC

Reuters
·
Feb 06

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist From Nasdaq and Deregister With SEC

THOMSON REUTERS
·
Feb 06

Anebulo Pharmaceuticals - Stock to Trade Privately & on Otc Market Post-Delisting

THOMSON REUTERS
·
Feb 06

Anebulo Pharmaceuticals Buys Back 300,000 Shares at $3.50 Each for $1.05 Million

Reuters
·
Jan 29

Anebulo Pharmaceuticals Buys Back 300,000 Shares for $1.05 Million

Reuters
·
Jan 27

Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results

TIPRANKS
·
Jan 27

Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer

THOMSON REUTERS
·
Jan 27

Anebulo Pharmaceuticals Launches Self Tender Offer to Buy Back 300,000 Shares at $3.50 Each for $1,050,000 USD

Reuters
·
Dec 22, 2025

Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer

THOMSON REUTERS
·
Dec 22, 2025

Anebulo Pharmaceuticals Inc - to Buy up to 300,000 Shares at $3.50 per Share

THOMSON REUTERS
·
Dec 22, 2025

Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate

Benzinga
·
Nov 14, 2025

Anebulo Pharmaceuticals posts Q1 net loss

Reuters
·
Nov 14, 2025

Anebulo Pharmaceuticals Board Approves Reverse Stock Split

Reuters
·
Nov 14, 2025

Anebulo Pharmaceuticals reports first quarter net loss of $0.05 per share

Reuters
·
Nov 14, 2025

Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)

TIPRANKS
·
Nov 14, 2025

Anebulo Pharmaceuticals, Inc. Q1 EPS USD -0.05

THOMSON REUTERS
·
Nov 14, 2025

Press Release: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Dow Jones
·
Nov 14, 2025

Anebulo Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025

Anebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock Split

TIPRANKS
·
Oct 02, 2025